Member Contact: Anne De Luca
Industry: Industry Support Services
Molecule2Market (M2M) is a team of clinical research professionals dedicated to advancing Australia’s contribution to the research and development of innovative medical treatments. Combining the strength of our expertise and experience we provide high quality services across all phases of clinical research and a broad range of therapeutic areas.
M2M provides a core staff of dedicated clinical research professionals and a team approach to all consulting projects. M2M 's team is highly experienced and covers all major Australian cities, offering:
• Short lead times for new staff
• Minimised interstate travel
• Strong local relationships with Key Opinion Leaders enabling us to offer a cost effective study start-up/ monitoring/project management solution
M2M provides services covering all aspects of clinical research, including:
• Project feasibility
• Site selection
• Study start-up (including ethics/regulatory submissions and contract negotiation)
• Project management
• Patient recruitment
• Local safety reporting
• Quality review and audit preparation
• Site close out
Our Directors Anne De Luca and Robin Hansen are able to leverage over 40 years collective experience in all facets of clinical trials to ensure M2M consistently delivers successful client outcomes.
All M2M consultants have a minimum of 15 years’ experience across Phase I-IV studies from start-up to close out.
Molecule2Market offers our clients the simplicity of support through one organisation. We provide services across a range of disciplines involved in pharmaceutical and device research, development and commercialisation in a highly flexible manner to meet customer needs.
• Quality Assurance and Auditing
• Data Management/Statistics
• Medical Writing
• Medical Monitoring
• Applying the Australian R&D Tax Incentive when Conducting Research in Australia